Stem Cell Products in Development

A range of stem cell products are currently under development including:

• Defined methods for the differentiation of stem cells into bone, lung and cardiac cells;
• Platforms for toxicology screening using Human Type II Pneumocytes; and,
• Bioreactors (the “TheraMachine”) for the scale-up of stem cell culture for both maintenance and directed differentiation.

The above products are available for partnership and/or licensing. For further information please contact info@novathera.com.

back